KalVista Pharmaceuticals Inc. (KALV) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, 3
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-10-25
5:16 pm
Purchase
2021-10-2113GKalVista Pharmaceuticals, Inc.
KALV
Deep Track Capital, LP1,266,884
5.180%
1,266,884increase
(New Position)
Filing
History
2021-09-17
4:54 pm
Purchase
2021-09-0713GKalVista Pharmaceuticals, Inc.
KALV
SUVRETTA CAPITAL MANAGEMENT, LLC1,296,452
5.300%
1,296,452increase
(New Position)
Filing
History
2021-06-10
11:37 am
Sale
2021-06-0913GKalVista Pharmaceuticals, Inc.
KALV
FMR LLC1,011,500
4.141%
-628,778decrease
(-38.33%)
Filing
History
2021-05-27
4:44 pm
Purchase
2021-05-2413GKalVista Pharmaceuticals, Inc.
KALV
RA Capital Management, L.P.1,399,489
5.700%
613,219increase
(+77.99%)
Filing
History
2021-05-07
4:56 pm
Purchase
2021-04-2713GKalVista Pharmaceuticals, Inc.
KALV
James E. Flynn1,806,037
7.430%
1,806,037increase
(New Position)
Filing
History
Goto Prev, 0, 1, 2, 3